title: Global Distribution of Campylobacter jejuni Penner Serotypes: A Systematic Review.
abstract: Penner serotyping has been the principal method for differentiating Campylobacter isolates since its inception. Campylobacter capsule polysaccharide (CPS), the principal serodeterminant on which Penner serotyping is based, is presently of interest as a vaccine component. To determine the required valency of an effective CPS-based vaccine, a comprehensive understanding of CPS distribution is needed. Because of the association between Penner serotype and CPS, we conducted a systematic review to estimate the frequency and distribution of Penner serotypes associated with cases of Campylobacteriosis. In total, more than 21,000 sporadic cases of C. jejuni cases were identified for inclusion. While regional variation exists, distribution estimates indicate that eight serotypes accounted for more than half of all sporadic diarrheal cases globally and three serotypes (HS4 complex, HS2, and HS1/44) were dominant inter-regionally as well as globally. Furthermore, a total of 17 different serotypes reached a representation of 2% or greater in at least one of the five regions sampled. While this review is an important first step in defining CPS distribution, these results make it clear that significant gaps remain in our knowledge. Eliminating these gaps will be critical to future vaccine development efforts.
authors.affiliation: Enteric Diseases Department, Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, Maryland, United States of America.
authors.forename: Brian L
authors.initials: BL
authors.lastname: Pike
authors.forename: Patricia
authors.initials: P
authors.lastname: Guerry
authors.forename: Frédéric
authors.initials: F
authors.lastname: Poly
mesh_terms: D000818:Animals; D015373:Bacterial Typing Techniques; D002169:Campylobacter Infections / Q000453:epidemiology* / Q000382:microbiology; D016123:Campylobacter jejuni / Q000145:classification* / Q000276:immunology; D014943:Global Health; D006801:Humans; D015995:Prevalence; D065288:Serogroup